Cargando…
Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
In recent years, researchers have leveraged the ubiquitin-proteasome system (UPS) to induce selective degradation of proteins by E3 ubiquitin ligases, which has great potential as novel therapeutics for human diseases, including cancer and neurodegenerative disorders. However, despite extensive effo...
Autores principales: | Aminu, Bayonle, Fux, Julia, Mallette, Evan, Petersen, Nathaniel, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029692/ https://www.ncbi.nlm.nih.gov/pubmed/35454069 http://dx.doi.org/10.3390/biom12040479 |
Ejemplares similares
-
Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy
por: Liu, Qi, et al.
Publicado: (2021) -
Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
por: Guo, Yusong, et al.
Publicado: (2021) -
53BP1 is a reader of the DNA damage-induced H2A Lys15 ubiquitin mark
por: Fradet-Turcotte, Amélie, et al.
Publicado: (2013) -
Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
por: Radhakrishnan, Sridhar, et al.
Publicado: (2022) -
Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer
por: Villiard, Éric, et al.
Publicado: (2007)